Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) — Analysis Summary
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) has a market cap of $41.13B with year-over-year revenue growth of +4.3%. Net margin stands at 8.2%. The stock trades at a P/E ratio of 26.3.
Key Takeaways
- Revenue changed +4.3% year-over-year
- Net margin of 8.2%
- P/E ratio of 26.3
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, TEVA posted revenue growth of +4.3% and trades at a P/E of 26.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.